Swedish Orphan Biovitrum AB: EMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia A
STOCKHOLM, May 19, 2023 /PRNewswire/ -- Sobi today announced that the European Medicines Agency (EMA) has accepted and validated a marketing authorisation application for efanesoctocog alfa
Nordrhein Westfalen United States Prnewswire Sobi Gewinn Nur Sobi Investor Relations Team European Medicines Agency
Source: finanznachrichten.de